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Abstract
Background: Thigh pain and cortical hypertrophies (CH) have been reported in the short term for specific short hip
stem designs. The purpose of the study was to investigate 1) the differences in clinical outcome, thigh pain and
stem survival for patients with and without CHs and 2) to identify patient and surgery-related factors being
associated with the development of CHs.
Methods: A consecutive series of 233 patients with 246 hips was included in the present retrospective diagnostic
cohort study, who had received a total hip arthroplasty (THA) between December 2007 and 2009 with a
cementless, curved, short hip stem (Fitmore, Zimmer, Warsaw, IN, USA). Clinical and radiographic follow-up,
including the radiographic parameters for hip geometry reconstruction, were prospectively assessed 1, 3, and 6 to
10 years after surgery.
Results: Cortical hypertrophies were observed in 56% of the hips after a mean of 7.7 years, compared to 53% after
3.3 years being mostly located in Gruen zone 3 and 5. There was no significant difference for the Harris Hip Score
and UCLA score for patients with and without CHs. Only one patient with a mild CH in Gruen zone 5 and extensive
heterotopic ossifications around the neck of the stem reported thigh pain. The Kaplan Meier survival rate after 8.6
years was 99.6% (95%-CI; 97.1–99.9%) for stem revision due to aseptic loosening and no association with CHs could
be detected. Postoperative increase in hip offset was the only risk factor being associated with the development of
CHs in the regression model (ΔHO; OR 1.1 (1.0–1.2); p = 0.001).
Conclusions: The percentage of cortical hypertrophies remained almost constant in the mid-term compared to the
short-term with the present cementless short hip stem design. The high percentage of cortical hypertrophies seems
not be a cause for concern with this specific implant in the mid-term.
Level of evidence: Diagnostic Level IV
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Background
Short hip stems show excellent survival rates ranging
from 95 to 100% after 3 to 11 years, comparable to con-
ventional cementless stems [1–6], but there is a lack of
long-term data. Some disadvantages have been reported
with short stems. Thigh pain occurred in 25% of patients
after 2 to 4 years with the Tri-Lock Bone Preservation
Stem (DePuy,Warsaw, IN,USA) and correlated with
younger patient age, while only 2% of the hips showed
cortical hypertrophy (CH) [7]. In contrast, a high rate of
29 to 63% for proximal femoral CHs was reported after
1.3 to 3.3 years with a cementless, curved, short stem
(Fitmore, Zimmer, Warsaw, IN, USA), which is subject
to the present investigation, while only 4% of the pa-
tients reported thigh pain [5, 8].
There is little evidence in the literature on factors con-
tributing to the development of thigh pain and cortical
hypertrophies and how they are associated [5, 7]. It has
been hypothesized, both clinical findings might be re-
lated to the modulus mismatch between the distal part
of the stem and the proximal femur affecting bone re-
modeling [7, 9]. This hypothesis is supported by a bio-
mechanical study examining the mediolateral bending
behavior of cementless stems, demonstrating a higher ri-
gidity for a short compared standard tapered stem [9].
However, the definite relationship between thigh pain,
cortical hypertrophies, load transmission and proximal
implant loosening is still a matter of debate. As thigh
pain and cortical hypertrophies may be of high clinical
relevance with short hip stems, mid-term studies with
adequate study cohort size are needed.
Therefore the present retrospective cohort study
questioned
1) What are the differences in clinical outcome, thigh
pain and stem survival for patients with and
without CHs and
2) What patient and surgery-related factors are associ-
ated with the development of CHs?
Methods
Study cohort
The present retrospective diagnostic cohort study inves-
tigated a consecutive series of 233 patients with 246
cementless THAs from a single academic institution.
The short-term results on the first 100 THAs have been
previously published by the senior author in BMC Mus-
culoskeletal Disorders reporting a percentage of 63% for
proximal femoral CHs after 3.3 years [5]. In order to
achieve a sufficient statistical power, all 233 patients
were included in the study group, who had received a
cementless THA between December 2007 and 2009 with
a specific bone preserving curved stem (Fitmore stem,
Zimmer, Warsaw, IN, USA), including the patients who
had been followed in the previous short term study [5].
Indications for receiving the short stem were absence of
severe proximal femoral deformity, adequate bone stock
for cementless fixation and the diagnosis of primary
osteoarthritis, developmental dysplasia of the hip (Crowe
grade I), avascular necrosis of the femoral head, post-
traumatic osteoarthritis, rheumatoid arthritis, slipped
epiphysis of the femoral head or Perthes disease. The
stem design for implantation was selected independently
by each surgeon based on best endosteal press-fit fix-
ation in the proximal femur and most accurate hip
geometry reconstruction for hip offset and leg length
difference according to templating [10]. Patients with bi-
lateral THA or prior hip surgery were included in the
study cohort. Diagnoses leading to THA and patient
demographics are given in Table 1. In deceased patients,
revision surgery between the last clinical follow-up and
death was excluded using information from relatives,
health insurance, general practitioners and clinical notes.
Informed consent was obtained by all patients. The
study was approved by the institutional review board
(S—083/2017) and conducted according to the Helsinki
Declaration of 2008.
Implants & Surgery
A cementless, curved, short stem was used in all patients
(Fitmore stem, Zimmer, Warsaw, IN, USA). The titan-
ium alloy stem (Ti Al6V4) has a porolock Ti-VPS coat-
ing in the proximal part to enhance bone ingrowth and
is available in four different neck angle options (127°,
129°, 137°, 140°) [8, 11]. The stem has a triple-tapered
design to achieve press-fit fixation at the metaphyseal/
diaphyseal level and according to the recommended
femoral neck resection level, this stem can be classified
as a trochanter-sparing or neck-harming short stem (Fig.
1) [5, 12, 13]. A cementless press-fit cup was used in 243
THAs (Allofit cup, Zimmer, Warsaw, IN, USA, 241 hips;
Pinnacle cup, DePuy Synthes, West Chester, PA, USA, 2
hips). A reinforcement ring was used in two THAs due
to one dysplastic and one posttraumatic acetabulum
(Ganz reinforcement ring, Zimmer, Warsaw, IN, USA).
A cemented cup was used in one THA due to osteope-
nia of the acetabular bone (Durasul, Zimmer, Warsaw,
IN, USA).
Ceramic heads with three neck length options (− 4, 0,
4 mm; 28 mm or 32mm diameter; Biolox forte®, Ceram-
Tec, Plochingen, Germany; 234 hips) or a CoCr femoral
head with one neck length option (8 mm; 32 mm diam-
eter; Metasul, Zimmer, Warsaw, IN, USA, 11 hips;
Articul, DePuy Synthes, West Chester, PA, USA, one
hip)) articulated with a highly cross-linked polyethylene
liner (Durasul®; Zimmer, Warsaw, IN, USA). Hard on
soft bearings with highly cross linked polyethylene liners
were used in 244 THAs and ceramic on ceramic
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bearings were used in two THAs (Biolox, CeramTec,
Plochingen, Germany).
Surgery was performed by five consultant surgeons in
a university hospital setting using a modified, anterolat-
eral Watson-Jones or a transgluteal Bauer approach. In-
traoperative fluoroscopy was used in all patients with
the final cup implant and the templated femoral broach
in situ. Surgeons aimed for secure press-fit fixation, neu-
tral stem alignment for varus/valgus position, antever-
sion of the stem of 10° ±10°, combined cup inclination/
anteversion between 40 ± 10°/20 ± 10°, balanced leg
length and reconstruction of the hip offset [14]. Stan-
dardized preoperative planning of the prosthesis size and
position was performed in all patients.
Clinical and radiographic assessment
Patients had clinical and radiographic follow-up exami-
nations in regular intervals at 1, 3, and 5 to 10 years
postoperatively. Preoperatively and at each time of
follow-up, the Harris hip score (HHS) and the University
of California, Los Angeles (UCLA) activity score were
assessed [15, 16]. Standardized digital, calibrated AP hip,
lateral hip and low-centred AP radiographs of the pelvis
were acquired [17]. Radiographs were assessed as previ-
ously described for implant loosening, radiolucent lines,
osteolysis, heterotopic ossification and cortical hypertro-
phies by two reviewers (MMI; JW), who were not in-
volved in index surgery and blinded to each other [5].
Implant loosening was defined by the criteria of Engh et
Table 1 Demographics and diagnosis for patients with and without cortical hypertrophies
Hips with CHs Hips without CHs p-value
Demographics
Number of hips 105 83
Gender (m: w) 57: 48 29: 44 0.32
Age at surgery in years 61 (53–68) 60 (51–68) 0.92
BMI (kg/m2) 26 (23–28) 26 (24–28) 0.46
HHS preoperatively 59 (43–67) 62 (48–69) 0.25
HHS postoperatively (3.3y FU) 97 (93–100) 97 (92–100) 0.89
HHS postoperatively (7.7y FU) 98 (93–100) 96 (91–100) 0.47
UCLA Score preoperatively 4 (3–6) 5 (3–6) 0.15
UCLA Score postoperatively (3.3y FU) 7 (6–7) 7 (6–8) 0.35
UCLA Score postoperatively (7.7y FU) 7 (5–7) 7 (5–7) 0.79
Diagnosis
Primary osteoarthritis 61 46 0.71
Developmental dysplasia 22 28 0.05
Avascular necrosis 10 4 0.22
Posttraumatic osteoarthritis 4 1 0.27
Rheumatoid arthritis 5 4 0.93
Others 3 0 0.12
CH cortical hypertrophy, FU follow up; median values (interquartile range)
Fig. 1 Photograph of the Fitmore® hip stem
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al. [18]. Osteolysis was defined as area with reduced
bone stock or endostal resorption. Osteolysis, radiolucent
lines and cortical hypertrophies were evaluated using the
zones described by Gruen et al. [19]. Heterotopic ossifica-
tions were evaluated by the criteria of Brooker et al. [20].
The methods for radiographic measurements have been
described previously in detail [10]. Briefly, varus/valgus
stem alignment was measured as the difference in degrees
between stem axis and proximal femoral shaft axis. The
Canal Fill Index (CFI) was determined, to evaluate the
meta−/ diaphyseal filling of the femoral canal by the
cementless stem three centimeter below the lesser tro-
chanter [21, 22]. Acetabular and femoral offset (AO, FO)
were measured as the distance between the center of rota-
tion of the femoral head and ipsilateral teardrop figure
and the center of rotation and proximal femoral shaft axis,
respectively. The postoperative offset change (ΔAO and
ΔFO) was determined as the difference between pre- and
postoperative AO and FO. Hip offset was defined as the
sum of AO and FO [14]. Roman software V1.70 (Institute
of Orthopedics, Oswestry, UK) and ImageJ software V1.44
(National Institute of Health, USA) were used for radio-
graphic analysis.
At last follow-up, one patient of the study cohort was
lost, 14 patients (14 hips, 6%) had died with the stem in
situ, 2 patients (2 hips, 1%) had withdrawn their study
consent and 2 patients (2 hips, 1%) had needed stem re-
vision. Therefore, 214 patients (227 hips, 92%) were
available for clinical follow-up after a mean of 7.7 years
(6–10 years) with 188 patients having additional up to
date radiographs (Fig. 2).
Statistical analysis
After exploratory data analysis including Q-Q plots and
Kolmogorov–Smirnov tests, non- parametric tests were
used. Values are given as medians with interquartile
range. To answer the first study question, group com-
parisons were performed using the Wilcoxon log-rank-
or the Mann-Whitney-U-Test and stem survival was es-
timated using Kaplan-Meier survival analysis with 95%
confidence intervals (CI). Patients were censored at
death, at stem revision for different endpoints or at the
end of follow-up, whichever came first. With regard to
sample size, the survival was calculated to 8.6 years
with a minimum of 17 hips still being followed up [23].
To answer the second study question, 171 hips could
be included to calculate the odds ratios for potential
risk factors being associated with the occurrence of a
CH using a logistic regression model (in 11 patients
with bilateral THAs, only the first hip was included and
6 patients had incomplete data sets, leaving 171 pa-
tients for analysis). A sample size calculation was per-
formed according to the formula by Peduzzi et al. (n =
10 × k÷p) [24]. Based on the percentage (p) of 63% for
CHs found in a previous study [5], and six predictors
(k) being included in the regression model, a minimum
of 95 hips would be needed to achieve sufficient power.
We considered p-values of < 0.05 to be significant.
SPSS® Version 24.0 (IBM SPSS Statistics, IBM, Armonk,
NY, USA) and GraphPad Prism® Version 6.0 (GraphPad
Software, San Diego, CA) were used to record and
analyze the collected data. Intra- and interobserver
reliabilities were calculated for 24 randomly selected
data sets (10% of THAs), using average-
measureintraclass-correlation coefficients (ICC) with a
two-way random effects model for absolute agree-
ment. Repeated measurements for intra- observer reli-
ability were performed at day 1 and day 7 in a
blinded fashion. The inter- and intra-observer correl-
ation coefficients were excellent for radiographic mea-
surements (range, 0.931 (95% CI; 0.813–0.972) to
0.997 (95% CI; 0.994–0.999).
Fig. 2 Distribution of hips at last Follow-Up (FU). Clinical follow up included data on patient reported outcome measures, thigh pain and stem
survival. In patients with clinical and radiographic FU, additional up to date radiographs were available
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Results
Cortical hypertrophies were observed in 56% of the hips
(n = 105) and mostly distally located in Gruen zone 3
and 5, indicating a slight increase in the percentage of
CHs compared to previous follow-up (53% after 3.3
years). The distribution and change of radiolucencies
and hypertrophies are shown in Fig. 3. There was no sig-
nificant difference for the HHS and UCLA score for pa-
tients with and without CHs (HHS: 98 (93–100) vs. 96
(91–100) points, p = 0.47 and UCLA: 7 (5–7) vs. 7 (5–7),
(p = 0.79; (median (IQR)). One patient reported thigh
pain. In this patient a mild CH was observed in Gruen
zone 5 but extensive heterotopic ossification around the
neck of the stem. No patient with a decrease in hip off-
set by more than 1 cm showed a limp and no patient
with an increase in offset by more than 5mm showed
symptoms of a trochanteric bursitis. One stem revision
was performed after 1.8 years for aseptic loosening due
to continuous subsidence without primary fixation. A
second stem revision was performed after a fall on the
hip after 8.6 years for a periprosthetic Vancouver B2
fracture. The Kaplan Meier survival rate after 8.6 years
was 99.6% (95%-CI; 97.1–99.9%) for the endpoint “stem
revision due to aseptic loosening” and 93.7% (95%-CI,
66.5–98.9%) for the endpoint “all stem revisions” and no
association with CHs and stem revision could be de-
tected (Fig. 4 a&b).
An increase in hip offset was identified as the only risk
factor for the development of CHs in the regression
model (ΔHO; OR 1.1 (1.0–1.2); p = 0.001) (Table 2). Re-
garding effect size, median ΔHO was − 0.3 mm (− 7.7 –
− 3.8) for hips with and − 3.8 mm (− 4.9–3.5) without
CHs. The proportion of hips with CHs steadily increased
with the increase in hip offset and only the two sub-
groups with “under-reconstructed” hip offset (ΔHO < −
2.5 mm) showed a proportion of < 50% for hips with
CHs (Figs. 5 and 6).
Discussion
The concept of short femoral stems was recently de-
scribed as being attractive, but concerns were expressed
due to a lack of data in the literature and more struc-
tured and specific research was recommended [25]. It
was hypothesized that in the future, short stems may be-
come the norm, but we were a long way from that [25].
In the face of this current trend, the present findings re-
garding clinical outcome, thigh pain, stem survival and
cortical hypertrophies are of clinical relevance.
To our knowledge, this is the first study reporting a
constant high percentage of 56% of cortical hypertro-
phies for this specific cementless curved, short stem de-
sign in the mid-term after 6 to 10 years compared to the
short term after 2 to 4 years. Despite the present radio-
graphic findings, there was no difference in clinical
Fig. 3 Distribution of radiolucencies (RL) and cortical hypertrophies (CH) around the 188 hip stems with available radiographic follow-up. Figure
adapted according to Maier et al., 2015, BMC Musculoskeletal Disorders [5]
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outcome and stem survival for patients with and without
CHs and the only patient or surgery-related factor being
associated with the development of CHs was reconstruc-
tion of hip offset. Surgeons aimed to reconstruct hip off-
set in order to achieve optimal clinical outcome, which
has been recently demonstrated to correlate with accur-
ate HO reconstruction and minimized leg-length differ-
ence [14]. Under-reconstruction of hip offset should be
avoided as it is associated with inferior clinical outcome
and increased risk for dislocation, as soft tissue tension
is reduced, while potential negative effects of a slight in-
crease in hip offset are still controversially discussed [14,
26]. In the present study, subgroups with adequately re-
stored to increased hip offset (− 2.5 mm to > + 10mm)
demonstrated percentages of more than 50% for hips
with CHs. In order to achieve optimal outcome with this
short stem and reconstructing hip offset, the increased
likelihood of developing CHs might have to be accepted.
As no relevant number of radiolucencies or osteolysis
could be observed in the proximal Gruen zones and
stem survival was excellent in the mid-term, we suggest
interpreting the high percentage of CHs as bone
remodeling due to a potential distal load transfer but
not as a sign of proximal stem loosening.
Interpreting our results in context of the literature, the
large variety of short hip stems and different classifica-
tions have to be acknowledged [12, 13]. Applying the
classifications from the literature, the Fitmore stem can
be characterized as a trochanter-sparing or neck-
harming cementless stem [12, 13]. Due to the variety of
“short”-stem designs with individual patterns of cement-
less fixation and load transfer, the comparison of differ-
ent stem designs regarding bone remodeling and
occurrence of cortical hypertrophies is difficult. A sys-
tematic review and meta-analysis by Yan et al. reported
similar periprosthetic bone remodeling around several
short- and standard stems, with moderate quality evi-
dence [27]. In particular, bone remodeling of the Fitmore
stem compared to the CLS stem demonstrated signifi-
cantly less bone mineral density reduction in the distal,
lateral femur, equivalent to Gruen zones 2&3 in a pro-
spective randomized study [28]. This finding supports
our assumption, that the present distal femoral cortical
hypertrophies might be attributable to bone remodeling
with pronounced distal load transfer. However, surgeons
should be aware that asymptomatic CHs should be dis-
tinguished from symptomatic CHs presenting with thigh
pain because stress fractures around a short cementless
stem without trauma have been reported in rare cases
[29]. Stem survival was good in the present study with
93.7% after 8.6 years for the endpoint all stem revisions
comparing well to other trochanter sparing stem designs
with survival rates of 90 to 98% after 7 years [12]. Fur-
thermore, no trend towards an increased revision rate
for stems with CHs could be observed in our study while
the rate of CHs remained almost constant at 56% after
7.7 years compared to 53% after 3.3 years. With respect
Fig. 4 a&b: Kaplan Meier survival rate after 8.6 years for the endpoint A: "stem revision due to aseptic loosening (99.6%; 95%-CI; 97.1-99.9%) and
for B: “all stem revisions” (93.7%; 95%-CI; 66.5–98.9%) (n = 246)
Table 2 Logistic regression model expressing the increased
likelihood for the development of CHs dependent on hip offset
reconstruction. (Nagelkerkes R2 = 0.118)
Model (n = 171) Odds Ratio (95%-CI) p-value
Stem axis 1.007 (0.881–1.151) 0.923
BMI 0.988 (0.921–1.059) 0.733
Age at surgery in years 0.989 (0.962–1.016) 0.405
Gender 0.608 (0.306–1.21) 0.157
Canal Fill Index 1.817 (0.092–36.007) 0.581
Δ Hip Offset in mm 1.104 (1.044–1.168) 0.001*
*indicating significance (p < 0.05)
Innmann et al. BMC Musculoskeletal Disorders          (2019) 20:261 Page 6 of 9
Fig. 5 Histogram showing the distribution and proportion of hips with and without CHs depending on hip offset reconstruction (ΔHO). Patients
with adequate or over-reconstructed hip offset demonstrated a higher proportion of hips with cortical hypertrophies (n = 188)
Fig. 6 Scatter plot showing hips with (black) and without CHs (grey), dependent on change in hip offset reconstruction, with hip offset being the
sum of femoral and acetabular offset (ΔHO =ΔFO +ΔAO) (n = 188)
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to clinical outcome, no difference could be demon-
strated for the HHS and UCLA score for patients with
and without CHs in the mid-term while thigh pain was
observed in only one patient.
The study has limitations that have to be addressed.
During the study period 246 of 836 THAs were per-
formed with the studied short stem and 506 with a
cementless tapered straight stem. The reviewed hip stem
was chosen by surgeons over the standard tapered
straight stem, when offering a more precise option of
press-fit fixation and hip anatomy reconstruction during
templating. Therefore, a potential preoperative selection
bias cannot be excluded due to the retrospective study
design, but we tried to minimize this bias by including
all patients with the short stem during the study period.
A further limitation due to the retrospective study de-
sign is that no bone mineral density measurements were
performed preoperatively and consecutively thereafter.
Nevertheless, the percentage of 76% for clinical and
radiological follow-up was high and only one patient
(0.5%) lost. In combination with the excellent ICCs, indi-
cating high reliability of the radiographic measurements,
the present study was adequately designed and powered
to answer our study questions. Although, the regression
analysis demonstrated that hip offset restoration was the
only risk factor being associated with the development
of CHs, the explanatory power of the model and clinical
relevance of hip offset restoration for the occurrence of
cortical hypertrohies has to be interpreted with caution
due to the small R2-value (0.118) and the wide 95%-CI
for the canal fill index. Therefore, the model might be
underpowered for the factor canal fill index. Lastly, stem
design results in an individual fixation pattern and load
transmission to the proximal femur. Therefore, care
must be taken when applying the presented findings on
cortical hypertrophies and thigh pain to different stem
designs.
Conclusion
Excellent clinical outcome, without differences for thigh
pain and stem survival was observed for patients with
and without CHs. The only patient and surgery-related
factor being associated with the development of CHs
was the change in hip offset. Therefore, we assume that
the high percentage of cortical hypertrophies is not a
cause for concern with this specific stem design in the
midterm, but long term follow-up is needed to confirm
this assumption.
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